Biotechnology & medicine

Frank Lyko

Aims to reprogram cancer cells to be more like normal cells by developing compounds that block the aberrant modification of DNA in cancer cells.

Year Honored
2004

Organization
Group leader, German Cancer Research Center

Region
Global